The most prominent example for the successful story of personalized medicine is the discovery of the BCR-ABL1 fusion gene that is formed via interchromosomal rearrangement in 95% of patients with chronic myeloid leukemia (CML). This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.